NC
IMTX icon

nVerses Capital’s Immatics IMTX Stock Holding History

nVerses Capital’s Portfolio IMTX Stock Details IMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200
Closed -$2.28K – 414
2024
Q3 		$2.28K Sell
200
-800
-80% -$9.47K ﹤0.01% 953
2024
Q2 		$11.6K Sell
1,000
-400
-29% -$4.51K 0.01% 876
2024
Q1 		$14.7K Buy
+1,400
New +$16.3K 0.04% 445

Other funds holding IMTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

nVerses Capital's IMTX Position: Q4 2024 in Review

nVerses Capital sold out of Immatics (IMTX) in Q4 2024, closing a stake of 200 shares — an estimated $2.28K sold.

nVerses Capital first reported a position in IMTX in Q1 2024 and held it in 3 quarters. The position peaked at $14.7K in Q1 2024. 85 funds tracked by Wall St. Rank hold IMTX as of Q4 2024.

  • nVerses Capital reported no remaining Immatics position as of Q4 2024 after selling out during the quarter.
  • nVerses Capital sold 200 Immatics shares in Q4 2024, an estimated $2.28K.
  • nVerses Capital first reported a position in Immatics in Q1 2024 and held it in 3 quarters.
  • nVerses Capital's Immatics position peaked at $14.7K in Q1 2024.
  • 85 funds tracked by Wall St. Rank held Immatics as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.